Adaptive Biotechnologies Corp (ADPT) › Cost of RevenueAdaptive Biotechnologies Corp (ADPT) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2017: $15.68M2018: $19.67M2019: $22.27M2020: $22.53M2021: $49.30M2022: $57.91M2023: $75.55M2024: $72.08M2025: $71.36M$71.36M2017Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$71.36M-1.0%2024$72.08M-4.6%2023$75.55M+30.5%2022$57.91M+17.5%2021$49.30M+118.8%2020$22.53M+1.1%2019$22.27M+13.2%2018$19.67M+25.4%2017$15.68M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share